Europe has led many aspects of gene research and yet it has been unable to
translate these discoveries into a globally dominant industrial sector. The
re are valid societal, political and financial reasons for its reluctance t
o deploy agricultural biotechnology but this reluctance might have unintend
ed consequences. It will be hard to de-commoditize agriculture and improve
farmer's lives. Research in medical biotechnology and the global environmen
t might suffer. Europe could damage its overall economy and its global comp
etitive standing.